← Back to Nuqta Atlas
Editorially curated · sa-kaimrc-biobank
Saudi Biobank
National biospecimen and linked phenotype resource supporting disease research, precision medicine and population-health studies.
01 / Project overview
What the record establishes.
- Geographic scope
- National Saudi population, common and rare disease cohorts and population controls
- Project type
- National population biobank
- Research domain
- Precision health, population genomics and translational medicine
- Years
- Not stated
- Lifecycle status
- active
- Status basis
- The biobank had active recruitment/holdings reported in 2024 and announced ISO 20387 accreditation in May 2025.
- Status evidence date
- 2025-05-01
- Scale
- Long-term target of 200,000 participants; 53,338 participants and 589,461 biospecimens reported by mid-2024.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- King Abdullah International Medical Research Center (KAIMRC)
- Partner organizations
- Ministry of National Guard Health Affairs · King Saud bin Abdulaziz University for Health Sciences
- Organism / population
- Saudi participants with common or rare diseases and population controls
03 / Data and access
What exists and how it can be reached.
Data types
- biospecimens
- linked clinical and phenotype data
- genomics-ready samples
Data access
Application/controlled biobank access
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
Large national biobank with more than 50,000 participants, published operational profile and international accreditation.
Editorial note
Distinct from the Saudi Public Health Authority National Biobank despite similar national naming.
Sources
- primary record source Verified 2026-08-15
- additional record source Verified 2026-08-15
- additional record source Verified 2026-08-15
Release v0.2.0